PKM2は,内皮細胞におけるANGPT2による血管新生活性化を調節する
Qiangqiang Ge1, Jianan Guo2,3, Liyuan Ye1
1Shangyu People's Hospital of Shaoxing, Shaoxing University, Shaoxing, 312000, China.
Scientific reports
|August 26, 2025
まとめ
パイルー酸キナーゼ型M2 (PKM2) は,腫瘍の成長における重要なプロセスである内皮細胞の増殖,移転,および血管新生を駆動する. PKM2とその下流エフェクタである ANGPT2をターゲットにすることで,血管新生に関連する疾患に対する潜在的な治療戦略が提供されます.
科学分野:
- 生物化学
- 細胞生物学
- 腫瘍学
背景:
- 内皮細胞は血管壁の障壁を形成し 血管新生の鍵となり 再血管化に不可欠なプロセスです
- 内皮細胞による血管新生は腫瘍,肺高血圧,眼疾患などの病理に 関わっている.
- ピル酸キナーゼ型M2 (PKM2) は,重要な糖分分解酵素であり,代謝および転写の調節を通じて疾患の発生に影響を与えます.
研究 の 目的:
- 内皮細胞媒介血管新生におけるPKM2の役割を調査する.
- 血管新生に関与するPKM2のダウンストリーム標的を特定する.
- 血管新生に関連する疾患におけるPKM2-ANGPT2軸を標的とした治療の可能性を調査する.
主な方法:
- PKM2のノックダウンと内皮細胞の過剰発現
- 内皮細胞の増殖,移動,血管新生の評価
- 分子生物学技術を用いた下流標的の特定と検証
- ANGPT2補給試験について
主要な成果:
- PKM2のノックダウンにより,内皮細胞の増殖,移動,および血管新生が抑制されました.
- PKM2の過剰発現はこれらのプロセスを促進した.
- ANGPT2はPKM2の直接的な下流標的として特定されました.
- ANGPT2の補充はPKM2の抑制効果を回復させた.
結論:
- PKM2は,内皮細胞の増殖,移動,血管新生を調節する上で重要な役割を果たします.
- ANGPT2はPKM2が血管新生に及ぼす影響の重要な媒介である.
- PKM2- ANGPT2経路は血管新生における重要な調節メカニズムであり,潜在的な治療目標です.
関連する概念動画
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Mechanism of Angiogenesis
5.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


